BD's Q2 Revenues Drop Slightly While Biosciences Biz Rises 3 Percent | GenomeWeb

BD's Q2 Revenues Drop Slightly While Biosciences Biz Rises 3 Percent

Apr 28, 2009

NEW YORK (GenomeWeb News) – Becton Dickinson today reported that its second-quarter revenues were down less than 1 percent year over year, but its BD Biosciences segment managed three percent revenue growth for the quarter.

The Franklin Lakes, NJ-based maker of diagnostics, medical products, and life science research tools reported revenues of $1.74 billion for the three-month period ended March 31, down from revenues of $1.75 billion in the second quarter of 2008.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Breaking News

The Scan

More Reproducible

Two new Reproducibility Project: Cancer Biology studies have largely reproduced the original findings, ScienceInsider reports.

To Catch the Swap

DNA fingerprinting could catch some sample mix-ups at pathology labs, the New York Times says.

This Week in Cell

In Cell this week: DNA methylation and T cell exhaustion, longevity in C. elegans, and more.

Face of the Suspect

A Maryland police department has turned to DNA phenotyping to develop a suspect sketch, WJLA reports.